{"name":"Bracco Diagnostics, Inc","slug":"bracco-diagnostics-inc","ticker":"","exchange":"","domain":"braccodiagnostics.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":13,"colorKey":"immunology","drugs":[{"name":"Isovue","genericName":"Isovue","slug":"isovue","indication":"Other","status":"marketed"},{"name":"Arm 2 - Magnevist","genericName":"Arm 2 - Magnevist","slug":"arm-2-magnevist","indication":"Other","status":"marketed"},{"name":"CardioGen-82","genericName":"CardioGen-82","slug":"cardiogen-82","indication":"Other","status":"marketed"},{"name":"Iopamidol 370","genericName":"Iopamidol 370","slug":"iopamidol-370","indication":"Other","status":"marketed"},{"name":"Iopamidol 370 mgI/dL","genericName":"Iopamidol 370 mgI/dL","slug":"iopamidol-370-mgi-dl","indication":"Contrast enhancement for angiography and vascular imaging","status":"marketed"},{"name":"Iopamidol 370 mgI/mL","genericName":"Iopamidol 370 mgI/mL","slug":"iopamidol-370-mgi-ml","indication":"Contrast enhancement for angiography and vascular imaging","status":"marketed"},{"name":"Iopamidol injection 76%","genericName":"Iopamidol injection 76%","slug":"iopamidol-injection-76","indication":"Contrast enhancement for angiography and vascular imaging","status":"marketed"},{"name":"Isovue 250","genericName":"Isovue 250","slug":"isovue-250","indication":"Contrast enhancement for intravenous urography","status":"marketed"},{"name":"MULTIHANCE:","genericName":"MULTIHANCE:","slug":"multihance","indication":"Other","status":"marketed"},{"name":"Magnevist","genericName":"Magnevist","slug":"magnevist","indication":"Other","status":"marketed"},{"name":"MultiHance 0.05 mmol/kg","genericName":"MultiHance 0.05 mmol/kg","slug":"multihance-0-05-mmol-kg","indication":"MRI contrast enhancement for central nervous system imaging","status":"marketed"},{"name":"Non ionic contrast media comparator","genericName":"Non ionic contrast media comparator","slug":"non-ionic-contrast-media-comparator","indication":"Contrast enhancement in radiographic imaging procedures including angiography, CT imaging, and urography","status":"marketed"},{"name":"ProHance","genericName":"ProHance","slug":"prohance","indication":"Other","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Iodixanol 320","genericName":"Iodixanol 320","slug":"iodixanol-320","indication":"Radiographic contrast agent for coronary and peripheral angiography","status":"marketed"},{"name":"SonoVue-enhanced ultrasound","genericName":"SonoVue-enhanced ultrasound","slug":"sonovue-enhanced-ultrasound","indication":"Enhancement of ultrasound imaging for detection and characterization of focal lesions in liver, breast, and other organs","status":"phase_3"},{"name":"VISIPAQUE 270","genericName":"VISIPAQUE 270","slug":"visipaque-270","indication":"Coronary angiography and left ventriculography","status":"marketed"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"MultiHance 0.1 mmol/kg","genericName":"MultiHance 0.1 mmol/kg","slug":"multihance-0-1-mmol-kg","indication":"MRI of the central nervous system (CNS) in adults and pediatric patients (including term neonates) to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues","status":"marketed"}]}],"pipeline":[{"name":"Iodixanol 320","genericName":"Iodixanol 320","slug":"iodixanol-320","phase":"marketed","mechanism":"Iodixanol is a non-ionic, iso-osmolar contrast medium that provides radiographic visualization of blood vessels and organs during diagnostic imaging procedures.","indications":["Radiographic contrast agent for coronary and peripheral angiography","Contrast agent for computed tomography imaging","Contrast agent for other diagnostic imaging procedures requiring vascular or organ visualization"],"catalyst":""},{"name":"Isovue","genericName":"Isovue","slug":"isovue","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Arm 2 - Magnevist","genericName":"Arm 2 - Magnevist","slug":"arm-2-magnevist","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CardioGen-82","genericName":"CardioGen-82","slug":"cardiogen-82","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Iopamidol 370","genericName":"Iopamidol 370","slug":"iopamidol-370","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Iopamidol 370 mgI/dL","genericName":"Iopamidol 370 mgI/dL","slug":"iopamidol-370-mgi-dl","phase":"marketed","mechanism":"Iopamidol is a non-ionic iodinated contrast medium that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures.","indications":["Contrast enhancement for angiography and vascular imaging","Contrast enhancement for computed tomography (CT) imaging","Contrast enhancement for urography and other radiographic procedures"],"catalyst":""},{"name":"Iopamidol 370 mgI/mL","genericName":"Iopamidol 370 mgI/mL","slug":"iopamidol-370-mgi-ml","phase":"marketed","mechanism":"Iopamidol is a non-ionic iodinated contrast medium that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures.","indications":["Contrast enhancement for angiography and vascular imaging","Contrast enhancement for computed tomography (CT) imaging","Contrast enhancement for urography and other radiographic procedures"],"catalyst":""},{"name":"Iopamidol injection 76%","genericName":"Iopamidol injection 76%","slug":"iopamidol-injection-76","phase":"marketed","mechanism":"Iopamidol is a non-ionic iodinated contrast agent that increases radiodensity in blood vessels and tissues to enhance visualization during radiographic imaging procedures.","indications":["Contrast enhancement for angiography and vascular imaging","Contrast enhancement for computed tomography (CT) imaging","Contrast enhancement for urography and other radiographic procedures"],"catalyst":""},{"name":"Isovue 250","genericName":"Isovue 250","slug":"isovue-250","phase":"marketed","mechanism":"Isovue 250 is an iodinated contrast medium that increases radiodensity in blood vessels and tissues to enhance visualization during X-ray and CT imaging procedures.","indications":["Contrast enhancement for intravenous urography","Contrast enhancement for cerebral and peripheral arteriography","Contrast enhancement for venography","Contrast enhancement for CT imaging"],"catalyst":""},{"name":"MULTIHANCE:","genericName":"MULTIHANCE:","slug":"multihance","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Magnevist","genericName":"Magnevist","slug":"magnevist","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MultiHance 0.05 mmol/kg","genericName":"MultiHance 0.05 mmol/kg","slug":"multihance-0-05-mmol-kg","phase":"marketed","mechanism":"MultiHance is a gadolinium-based contrast agent that enhances magnetic resonance imaging (MRI) by shortening the T1 relaxation time of water protons in tissues.","indications":["MRI contrast enhancement for central nervous system imaging","MRI contrast enhancement for body imaging including liver lesion characterization"],"catalyst":""},{"name":"MultiHance 0.1 mmol/kg","genericName":"MultiHance 0.1 mmol/kg","slug":"multihance-0-1-mmol-kg","phase":"marketed","mechanism":"Water protons in tissue; blood-brain barrier; vascular endothelium","indications":["MRI of the central nervous system (CNS) in adults and pediatric patients (including term neonates) to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues","Magnetic Resonance Angiography (MRA) to evaluate adults with known or suspected renal occlusive vascular disease","Magnetic Resonance Angiography (MRA) to evaluate adults with known or suspected aorto-ilio-femoral occlusive vascular disease"],"catalyst":""},{"name":"Non ionic contrast media comparator","genericName":"Non ionic contrast media comparator","slug":"non-ionic-contrast-media-comparator","phase":"marketed","mechanism":"Non-ionic contrast media enhance the visibility of blood vessels and organs during radiographic imaging by increasing radiodensity without causing significant osmotic effects.","indications":["Contrast enhancement in radiographic imaging procedures including angiography, CT imaging, and urography"],"catalyst":""},{"name":"ProHance","genericName":"ProHance","slug":"prohance","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SonoVue-enhanced ultrasound","genericName":"SonoVue-enhanced ultrasound","slug":"sonovue-enhanced-ultrasound","phase":"phase_3","mechanism":"SonoVue is a microbubble contrast agent that enhances ultrasound imaging by reflecting ultrasound waves, improving visualization of blood flow and tissue perfusion.","indications":["Enhancement of ultrasound imaging for detection and characterization of focal lesions in liver, breast, and other organs","Assessment of myocardial perfusion and left ventricular opacification in echocardiography"],"catalyst":""},{"name":"VISIPAQUE 270","genericName":"VISIPAQUE 270","slug":"visipaque-270","phase":"marketed","mechanism":"Visipaque 270 is a non-ionic, iso-osmolar contrast medium that provides radiographic visualization of blood vessels and organs during diagnostic imaging procedures.","indications":["Coronary angiography and left ventriculography","Peripheral vascular angiography","Cerebral angiography","Renal angiography","Aortography"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOSmNNeUpTSDljSkVBMF9ZTEpKTmpaN2tpZjU5cXV6d0Q4b0xpX2dqMVNBRktqazNWb3l4dUJaYWRvazBudFZaeDNCVjhZTzlQRnpxRlJVX2dsek1Nb185WW1XM3BLYWhPSFZLel9RaEQyUkhQQVE4dXZsTk1QYndJMDZ3MXdSWXhf?oc=5","date":"2026-03-31","type":"pipeline","source":"Contract Pharma","summary":"Bracco Imaging Upgrades Geneva Site - Contract Pharma","headline":"Bracco Imaging Upgrades Geneva Site","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPUllWTVcySFA4YThRVWpHc3Q0YUp3a1RIMWlsVl8zWjVkTElTeEx0cTJ2bHJldHVqUlpMaDZ4clYybFVRZDFTZWNMV3Y1ejQ4ZEJ1NHkxYUR6Z0RnVE4wdUJBcU4zVVlGTUtOUU15VXNpNVpvWWxYS18yYkkxb29rYmJiVmNOU2dFZUxKY3JrVy1obUNRc0dJTzlYNDlUdXZx?oc=5","date":"2026-02-20","type":"earnings","source":"Statista","summary":"Worldwide revenue of the Italian pharmaceutical group Bracco in 2016, by business unit - Statista","headline":"Worldwide revenue of the Italian pharmaceutical group Bracco in 2016, by business unit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNOGFmekxGWHJBVFlQb0M1bDJFZmlld19od1EwOWtRdTZ3THQwUmFjUERCLTJWdUJ3NnRnMHNNWXJfMk1iVTdjNDJFUzluSl9Kajk4UmwtQXVkeHNfVE5fcUFuSDBPNWZ1UTREcVVSMDBLd0s4OGpEZi1Rak9NQ2dUb2pnWlFXeVI1b1l1T3hycU9yTFFqUjJFaUJ5cC1tVGFNT1ItWjVGRFppeWxaRjJIeTZjd3N0TDFzdTNxdC0wamZET2l2SXI0T1RDOVQzUGgxdm0xY1hRcUNMMldTMHc?oc=5","date":"2025-11-19","type":"regulatory","source":"PR Newswire","summary":"Bracco Delivers 3 Million VUEWAY® Doses, Meeting Patient Demand for Lower-Dose MRI Contrast - PR Newswire","headline":"Bracco Delivers 3 Million VUEWAY® Doses, Meeting Patient Demand for Lower-Dose MRI Contrast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQaXJkRFdfNkp0ZEJUYWE3dzRiTHZyTTNnWkhrQWFUV005QjdkTU5VQkJxMXBHRDFldDBfUjRWcDV3N1Q3MHkxVEJhZmJPVEFkcWMxVHM5R3ZkcjNjYTNMdk45dFRKdGVHYXZ1TUpWbEk3SHc3ZThzNXl1Tl9zTGpzVnd3ajVSVFBNVldwTlltdGRpWHB2WGNTZ05pLXcyVWxNS1ZDd29SdW04Vk9GYTV5Ykt1SGFQbWtMamRabHBR?oc=5","date":"2025-11-10","type":"pipeline","source":"PR Newswire","summary":"Bracco Shapes the Future of Radiology at RSNA 2025 Annual Meeting - PR Newswire","headline":"Bracco Shapes the Future of Radiology at RSNA 2025 Annual Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPek11Z2ptWkcyZnFmUE0zbW5UTm4zTzdqZzZLUG9OaVdsRGZUMVBJVElJZ3dZTlZCTVdmbVFNbVB2VFNGMi1XemwyZFpraWdiQnlWb3dueTh3YUI4MlAxQXdfTjRqTE9MaU1CMDJhVWlzbFpERUJ0U1FJRGlKS0FHX0k0ck5lVU44REY0MmtheTJBczZZLWw5Sk1HczJ4aXFPUnhnc3RHQVIxMUN3WTdGYTFWa3U2UjFkY2ZRMzBvdVlTcW1PUVhRMVhmaXpuSVRHOWY3dmVrNS1fT3VmQjdFUGp5NFBzcnpwZDNPUUxOc0FCeElWVzhQWHctUWZXVTRMUS1tZkl5cExGTWtfZEJ1aFBrb21WX0JKVGFaTFNVTnhQQldCdUl3dGtqaXNMZVAwdllV?oc=5","date":"2025-03-17","type":"pipeline","source":"PR Newswire","summary":"Bracco Diagnostics Inc. Launches Update to HeartSee™ With New Features and Expanded Access to Cutting-edge Technology for Coronary Artery Disease Diagnosis - PR Newswire","headline":"Bracco Diagnostics Inc. Launches Update to HeartSee™ With New Features and Expanded Access to Cutting-edge Technology fo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxNRmIyR3ROLXZ2TnltWGhVa2tMU2V5dGV0c003QnhXUlNRUi1EOWhoUl9FdWJjOUNnZEczU0lZajF3OWYxdkFPSlVXRUpiRkt1VlEtVWhEN1NrcnlkSjIwTF9Jc0pEMFQ2SjJ6WE4tN3V1LXRKUFMxSjBGNmw5NnRLZmtXZktfQU5aV3hhNndpdURGZTktbDMxMUJ0Y1hNQWgwb0xXSzhTOVZHcl9RMzh0VE9FSDVkeUUzVlZoLVNJYzJJNl81RmJRLUpzWHNUTVZWWTJaTHprM0pnbVNScE1CWnhmMktYczZESFB3djdldGR2bWJxU2pRTEVwVmdzaDVrUlRoMEVELWFqLVBkMzV4NF9uWExMU1Ezd2F6STZjcTVYak9fTVVFR0ZnQTZQcmpOMUw0QVUxM3BleFpMdkpjVW52eGZpTC1feHk4amdXWQ?oc=5","date":"2025-02-21","type":"deal","source":"PR Newswire","summary":"Bracco and the European Society of Radiology build on long-standing partnership at ECR 2025 through new campaign to advance innovative and sustainable approaches in radiology - PR Newswire","headline":"Bracco and the European Society of Radiology build on long-standing partnership at ECR 2025 through new campaign to adva","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNeldmZzJJZGtzc3hxZTV4MTI0bGV6Q19HUVlXT0t2QW4zc3c5aE4xaWFmZWk4cGtBdmxnYjdoYWFOeDY2Mk1RLUt6bVhUR2FIZGRTdUE4bk1aSDhqU2dEREI3TlVwQ20tUFRrX2xaSXgyWjRTdzloTFBLUFFqMUk1RE55Q0Zady1pT2lEbW50SnNUODVRb1ZfbVM4QXc0bC16YWllX1V2ekY1S2NxYTFPX3c2bmppYTU1REtn?oc=5","date":"2024-07-09","type":"pipeline","source":"Imaging Technology News","summary":"Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer - Imaging Technology News","headline":"Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOencxVGNGZjdwZVE2SGZyRlExcEZnQnpHLXJ0WHZ0U0ZWcWxkNGxSZkF3OWhnRmlvd2FvTTlzN1VDM1lEMW1qYjFhdGh1WVJ5VENjelJ4WkRGc2Q0ckYzbzFZaThSVGJsRTQ1d18wRGlSVmZRaExpZHZDT1BrV0VvSm5jcU9MVlNXT0VFQUdFV2hnXzV2bWJoT2VhaDBDTVFiQXViMHAzQ01lWlRFRG1CVWZiUWdwQ1ZiSUVxNF90YUFSdGs?oc=5","date":"2023-07-25","type":"trial","source":"Imaging Technology News","summary":"Bracco Imaging Announces Publication of Data Reinforcing Efficacy, Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions - Imaging Technology News","headline":"Bracco Imaging Announces Publication of Data Reinforcing Efficacy, Safety of Gadopiclenol in Contrast-Enhanced MRI of Ce","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOamI5UGZFRlgzdVFzcVF0YjlWQzJiQWtVMEU0Z2VVX1NxRUlyam1xV0Y3UHdzTDBpM2Y1a0U5UmtXRi0tY1Bxa1lLRTB0RUJDZi1KcmxZU195ZlZQNWxXUU9ZUy1VREhJbWEtc1pPcFZ2Y2g1U2wyTHdTVFk2ZmJVaWZucC10TUpHNDdXU3BUNlJMM2xIOWZmTU4xRHdYb0M3MWxQWk83T3Z3WlhrVWlfa3RQcHg4UWVzSnBVTzVPc24?oc=5","date":"2023-06-21","type":"patent","source":"Imaging Technology News","summary":"Fresenius Kabi Broadens Radiology Portfolio with its First-to-Market Authorized Generic, Sincalide for Injection - Imaging Technology News","headline":"Fresenius Kabi Broadens Radiology Portfolio with its First-to-Market Authorized Generic, Sincalide for Injection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOaGxsRWl0SllVNHViX0FJMzlrU2ZrVkVlRGdaVlJ0U1gxcWt4OGZZcG12a0lCa05JQ2Zlb3Rkbjl5ZUdUR003Mk9CdkVnSUk2M3pSRXNMcWhkWW1tSTBEMnpJUVJmb1ZVNW4wZEMxYk5HVDNRQzliLUtPNlhLOHFIdEtTRm1GczB6bE83N2VzaE1RRV9ZUjBoNUJMWm96UlJvTnVBVWVZT3dkQQ?oc=5","date":"2023-05-16","type":"pipeline","source":"Imaging Technology News","summary":"American College of Radiology Classifies VUEWAY as a Group II Agent Relative to NSF - Imaging Technology News","headline":"American College of Radiology Classifies VUEWAY as a Group II Agent Relative to NSF","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNQWNKYVhvREg1d1ZoUjdhT051T0hGQmt6cjEzcWxQWUN5UVZCdWtyUXBQWFNWQ3VibC1VWE9JMXV5YW5ma3BBcUV6UG5CVnM0dHYyRUI2Y0JSdU1VaElKdHNfSTFJOWY4SjZ1eXphSGVndzVENlVDLW82ay11WXdDbk9uNnZZTEQ1WUdLTjhtODhKTE0yNFRhV2c2WUhJUUdwcGxZUThYaFEySnpMc0ZBS0ktd281SGo3MkFmYkVuQml6Tm01LWVSd1VET0hMZ3JSbmE3dA?oc=5","date":"2018-05-22","type":"pipeline","source":"PR Newswire","summary":"Bracco Imaging and Shanghai Pharmaceuticals join forces in the field of ultrasound - PR Newswire","headline":"Bracco Imaging and Shanghai Pharmaceuticals join forces in the field of ultrasound","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPdXVPdDJOMjNJUTN4dDdxVld0emxmXzRlNUpyNXJBdTdtY1dFcXZsZXB5V2xUcEVYNzBHUDI2XzNkM2RXV0Viak4wb19nVHNWc1NlaFBlYzg0TTFTTG82TVRsVzh1dkhFajNvNjUwV2RPSFFzcDktVVh2ZmVIaGhLVGNISHR0WmJvS2d0VlRGUGg4ZmwyVWNGeEFPNktXWVVEVWRNT19RWENHME0zNFl0ZTVn?oc=5","date":"2015-12-10","type":"pipeline","source":"dicardiology.com","summary":"Bracco Creates Multi-Dose Compliant Contrast Medium for Point-of-Care Use in the CT Suite - dicardiology.com","headline":"Bracco Creates Multi-Dose Compliant Contrast Medium for Point-of-Care Use in the CT Suite","sentiment":"neutral"}],"patents":[],"drugCount":17,"phaseCounts":{"marketed":16,"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}